Companies: 48,687 Total Market Cap: 127170828859578.36

Becton, Dickinson and Company

NYSE: BDX
Healthcare Medical Instruments & Supplies
Rank #431
Market Cap 48.37 B
Volume 10.53 M
Price 168.78
Change (%) 0.45%
Country or region United States United States

Becton, Dickinson and Company's latest marketcap:

48.37 B

As of May 4, 2025, Becton, Dickinson and Company's market capitalization has reached $48.37 B. According to our data, Becton, Dickinson and Company is the 431th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 48.37 B
Revenue (ttm) 20.87 B
Net Income (ttm) 1.50 B
Shares Out 286.61 M
EPS (ttm) 5.16
Forward PE 11.82
Ex-Dividend Date June 9, 2025
Earnings Date May 1, 2025
Market Cap Chart
Data Updated: May 4, 2025

Becton, Dickinson and Company's yearly market capitalization.

Becton, Dickinson and Company has seen its market value grow from $10.59 B to $58.89 B since 1998, representing a total increase of 455.79% and an annual compound growth rate (CAGR) of 6.73%.
Date Market Cap Change (%)
April 25, 2025 $58.89 B -10.23%
December 31, 2024 $65.59 B -7.37%
December 29, 2023 $70.81 B -1.74%
December 30, 2022 $72.06 B 0.89%
December 31, 2021 $71.43 B -1.58%
December 31, 2020 $72.57 B -1.34%
December 31, 2019 $73.56 B 21.69%
December 31, 2018 $60.44 B 23.86%
December 29, 2017 $48.80 B 38.84%
December 30, 2016 $35.15 B 8.24%
December 31, 2015 $32.47 B 21.55%
December 31, 2014 $26.72 B 24.57%
December 31, 2013 $21.45 B 39.26%
December 31, 2012 $15.40 B -4.09%
December 30, 2011 $16.06 B -17.39%
December 31, 2010 $19.44 B 3.94%
December 31, 2009 $18.70 B 12.46%
December 31, 2008 $16.63 B -18.44%
December 31, 2007 $20.39 B 17.82%
December 29, 2006 $17.30 B 14.26%
December 30, 2005 $15.14 B 5.26%
December 31, 2004 $14.39 B 37.33%
December 31, 2003 $10.48 B 32.87%
December 31, 2002 $7.88 B -8.07%
December 31, 2001 $8.58 B -2.81%
December 29, 2000 $8.82 B 30.37%
December 31, 1999 $6.77 B -36.12%
December 31, 1998 $10.59 B

Company Profile

About Becton, Dickinson and Company

Becton, Dickinson and Company (BD) is a global medical technology company that develops, manufactures, and sells a wide range of medical supplies, devices, laboratory equipment, and diagnostic products. Serving healthcare institutions, physicians, researchers, clinical laboratories, and the pharmaceutical industry, BD operates through three key segments:

BD Medical Segment

This segment focuses on medication management and patient safety solutions, including:

  • Vascular Access: Peripheral IV catheters, central lines, dialysis catheters, and vascular care products.
  • Medication Delivery: Needle-free IV connectors, closed-system drug transfer devices, and infusion therapy systems.
  • Pharmacy Automation: Automated dispensing, inventory tracking, and compounding workflow systems.
  • Prefillable Solutions: Drug delivery systems and hypodermic syringes.

BD Life Sciences Segment

This segment provides diagnostic and research tools, such as:

  • Specimen Collection: Blood collection products and liquid-based cytology systems.
  • Microbiology Solutions: Automated culturing, molecular testing, and rapid diagnostic assays.
  • Flow Cytometry: Cell sorters, analyzers, and reagents for clinical and research applications.

BD Interventional Segment

This segment offers surgical and interventional products, including:

  • Surgical Repair: Hernia and soft tissue grafts, biosurgery products.
  • Infection Prevention: Solutions to reduce surgical infections.
  • Urology & Critical Care: Specialized medical devices for patient care.

Founded in 1897, BD is headquartered in Franklin Lakes, New Jersey, and continues to innovate in medical technology worldwide.

Frequently Asked Questions

As of May 4, 2025, Becton, Dickinson and Company (including the parent company, if applicable) has an estimated market capitalization of $48.37 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Becton, Dickinson and Company global market capitalization ranking is approximately 431 as of May 4, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 1897
IPO Date n/a
Employees 73,000
CEO Thomas Polen
Sector Healthcare
Industry Medical Instruments & Supplies
Address 1 Becton Drive
Franklin Lakes, New Jersey 07417-1880
United States